维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Vantomme V"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Identification of MAGE-3 Epitopes presented by HLA-DR molecules to CD4+ T lymphocytes显示文摘	Chaux P Vantomme V Stroobant V	1999	J Exp Med1999，185，5：	1
	2	A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cwt6显示文摘	Vantomme V Bo?l P Plaen E	2003	Cancer Immunity2003，3，17：	1
	3	Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes显示文摘	Chaux P Vantomme Stroobant V	1999	JExp Med1999，189，5：	1
	4	Mixed numerical- experimental technique for orthotropic parameter identification using biaxial tensile tests on cruciform specimens 显示文摘	Lecompte D Smits A Sol H Vantomme J Hemelrijck D V	2007	International Journal of Solids and Structures2007，44，5：	1
	5	Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-posi-tive tumors显示文摘	Vantomme V Dantinne C Amrani N	2004	J Immunother2004，27，2：	1
	6	Immunologicanalysis of a phase Ⅰ/Ⅱ study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3 -positive tumors显示文摘	Vantomme V Dantinne C Amrani N	2004	J Immunother2004，27，2：	1
	7	Immunologic analysis of a phase Ⅰ/Ⅱ study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE -3 -positive tumors显示文摘	Vantomme V Dantinne C Amrani N	2004	J Immunother2004，27，：	1
	8	Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes显示文摘	Vantomme V Stroobant V	1999	J Exp Med1999，189，5：	1
	9	Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymhocytes显示文摘	Chaux P Vantomme V Stroobant V	1999	J Exp Med1999，189，5：	1
	10	Identification of MAGE-3 Epitopes presented by HLA-DR molecules to CD4+T lymphocytes 显示文摘	Chaux P Vantomme V Stroobant V	1999	J Exp Med1999，185，5：	1
	11	Immunologic analysis of a phase Ⅰ/Ⅱ study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors 显示文摘	Vantomme V Dantinne C Amrani N	2004	J Immunother2004，27，2：	1
	12	Immunologic analysis of a phase Ⅰ/Ⅱ study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors 显示文摘	Vantomme V Dantinne C Amrani N	2004	J Immunother2004，27，2：	1
	13	查看详情显示文摘	Li Y Yang X Y Tian G Vantomme A Yu J G Tendeloo G V Su B L		0，，：	1
	14	Immunologic analysis of a phase I/Ⅱ study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors显示文摘	Vantomme V Dantinne C Amrani N	2004	J Immunother2004，27，2：	1
	15	Identification of MAGE-3epitopes presented by HLA-DR molecules to CD4( + ) T lympho-cytes显示文摘	Chaux P Vantomme V Stroobant V	1999	J Exp Med1999，189，5：	1
	16	Immunologic analysis of a phase Ⅰ/Ⅱ study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors显示文摘	Vantomme V Dantinne C Amrani N	2004	J Immunother2004，27，2：	1
	17	Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer 显示文摘	Chaux P Vantomme V Coulie P	1998	Int J Cancer1998，77，4：	1
	18	Mesoporous and nanostructured CeO2 as supports of nano-sized gold catalysts for low-temperature water-gaa shift reaction显示文摘	YUAN Zhong-yong IDAKIEV V VANTOMME A	2008	Catalysis Today2008，131，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费